EGFR and incontinentia pigmenti: Similarly, epidermal growth factor receptor (EGFR) mutations have been implicated in both the pathogenesis and malignant potential of IP, with studies indicating that EGFR exon 20 mutations may represent a distinct molecular subtype with increased risk for recurrence [19, 20].